Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-036435
Filing Date
2019-06-19
Accepted
2019-06-19 18:31:29
Documents
2
Period of Report
2019-06-19

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2844
2 EX-24 ex-24.htm EX-24 9307
  Complete submission text file 0001104659-19-036435.txt   13510
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Issuer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
White William Richard (Reporting) CIK: 0001778739 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38944 | Film No.: 19907129